Business · 21/04/2005

FDA Releases Guidance on User Fees for Combination Products

The Food and Drug Administration (FDA) has made available a guidance document that outlines the process for marketing application user fees for combination products, as well as the application of the 'barrier to innovation' waiver provision in certain situations.